argenx SE (NAS:ARGX)
$ 585.4 34.59 (6.27%) Market Cap: 35.18 Bil Enterprise Value: 30.03 Bil PE Ratio: 0 PB Ratio: 8.21 GF Score: 80/100

Full Year 2020 argenx SE Earnings Call Transcript

Mar 04, 2021 / 01:30PM GMT
Release Date Price: $291.28 (-7.89%)
Operator

Good morning. My name is Andrew, and I will be your conference operator today. Welcome to the argenx Full Year and Fourth Quarter 2020 Financial Results Conference Call. At this time, I would like to welcome everyone to the call. (Operator Instructions) Please note, this conference is being recorded. Thank you.

I'd like to introduce Beth DelGiacco, Vice President of Corporate Communications and Investor Relations. You may begin your conference.

Beth DelGiacco
argenx SE - VP of IR

Thank you. A press release was issued earlier today with our full year 2020 financial results and the business update. This can be found on our website along with the presentation for today's webcast.

Before we begin, I'd like to remind you on Slide 2 that forward-looking statements may be presented during this call. These may include statements about our future expectations, clinical development, regulatory time lines, the potential success of our product candidates, financial projections and upcoming milestones. Actual results may differ materially from those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot